Literature DB >> 27042786

Reducing Opioid Adverse Events: A Safe Way to Improve Outcomes.

Jay A Redan1, Tina Wells2, Sandra Reeder2, Steven D McCarus2.   

Abstract

INTRODUCTION: Opioids are commonly used in the postoperative period to manage postsurgical pain. However, adverse side effects of opioids include respiratory depression, urinary retention, pruritus, vomiting, nausea, constipation, and increased risk of falls. Surgical site infiltration with extended release liposomal bupivacaine is effective in the multimodal care plan of managing postsurgical patients. The purpose of the present study was to examine the possible effects of liposomal bupivacaine on postoperative opioid adverse events following open hernia repair and laparoscopic colon resection surgery.
MATERIALS AND METHODS: The study population comprised 82 patients who had undergone open hernia repair or a laparoscopic colon resection. Forty-five of the 82 patients were treated with liposomal bupivacaine. Data were examined retrospectively from January 1, 2012 to August 31, 2012 in comparison with historical controls. Adverse opioid events measured included constipation, pruritus, vomiting, nausea, urinary retention, respiratory depression and fall risk. Statistical tools used were the Mann-Whitney U test, Pearson's chi-squared test, and Fisher's exact test.
RESULTS: The addition of liposomal bupivacaine did significantly (p<0.05) reduce urinary retention and respiratory depression. Additionally, from the perspective of hospital safety there was a significant reduction in patients at high risk of falls, from 16% to 8.4% as well as an increase in patients at low risk of falls, from 37.6% to 48.7%.
CONCLUSION: The findings of this study demonstrate that using liposomal bupivacaine can significantly reduce high-risk fall patients, increase low-risk fall patients as well as decrease urinary retention and respiratory depression in the postoperative setting. Given heightened consideration of the impact of sentinel events on hospital reimbursement since health care reforms in 2014, these results are important because they can mitigate complications associated with opioids in postsurgical pain management, and thereby reduce the costs of hospitalization.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27042786

Source DB:  PubMed          Journal:  Surg Technol Int        ISSN: 1090-3941


  6 in total

1.  Effects of menstrual cycle on nausea and vomiting after general anesthesia.

Authors:  Lan Zou; Shuai Miao; Lei Wang; GuangLei Wang
Journal:  J Anesth       Date:  2020-04-27       Impact factor: 2.078

2.  Bupivacaine liposome use reduces length of post-anesthesia care unit stay and postoperative narcotic use following robotic inguinal herniorrhaphy.

Authors:  Mariana Vigiola Cruz; James Senturk; Gregory Dakin; Cheguevara Afaneh; Omar Bellorin
Journal:  J Robot Surg       Date:  2021-11-06

3.  Palliative Management of Nonoperative Femoral Neck Fractures With Continuous Peripheral Indwelling Catheters: Case-Control Series.

Authors:  Christopher H Rashidifard; Nicholas Romeo; Mark Richardson; Paul Muccino; Thomas DiPasquale; Chelsea M Bush
Journal:  Geriatr Orthop Surg Rehabil       Date:  2019-03-11

Review 4.  A meta-analysis of dexamethasone for pain management in patients with total knee arthroplasty.

Authors:  Guanghong Zhou; Liping Ma; Junhai Jing; Hao Jiang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

5.  A cost-consequence analysis of parecoxib and opioids vs opioids alone for postoperative pain: Chinese perspective.

Authors:  Magdolna Barra; Edit Remák; Dong Dong Liu; Li Xie; Lucy Abraham; Alesia B Sadosky
Journal:  Clinicoecon Outcomes Res       Date:  2019-02-22

6.  Liposomal bupivacaine for the management of postsurgical donor site pain in patients with burn injuries: a case series from two institutions.

Authors:  Sharmila Dissanaike; Jayne McCauley; Carlo Alphonso
Journal:  Clin Case Rep       Date:  2017-12-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.